The page is the record's research on the issuer — no analyst, no rating, no view. # ADMA BIOLOGICS, INC. (NASDAQ: ADMA) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is ADMA BIOLOGICS, INC., listed on NASDAQ under ticker ADMA, with ISIN US0008991046 and LEI not on the record (no GLEIF record with the exact legal name in jurisdiction US-DE). Its security type is Corporate, its segment is not on the record, its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States, Delaware. Its listing status is listed, not halted. ## The disclosure read The record holds 52 filings in the twelve months to 2026-11-08, across 30 filing days. The median gap between filing days is 6 days, and the median latency from latest filing to record date is 3 days; the latest filing is dated 2026-11-05 and is of type directors_dealings. Filings by type are 28 directors_dealings, 9 regulatory_filing, 9 results, 3 corporate_news and 3 agm_egm. The NASDAQ exchange medians are 6.0 days cadence, 52 filings and 5.0 days latency across 4359 issuers; the sector medians for 2836 Biological Products, (No Diagnostic Substances) are 5.5 days cadence, 65.5 filings and 4.0 days latency across 176 issuers. ## Auditor The auditor of record is KPMG LLP, located in Stamford, Connecticut. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record (EDGAR states no dated change of state of incorporation on a filing line), and the segment move is not on the record (the exchanges' tier transfers are not EDGAR filings). The halt flag reads listed, not halted. ## Orderability The outcome is not determinable: the chapter's orderability section carries no client_categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page; the count is 0. ## Open research No openly published research notes were found; the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04, and the live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001368514.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/ADMA (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1368514/000114036126006815/ef20059416_10-k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/ADMA (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/ADMA · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp